Anal and rectal cancer in Crohn's disease

Colorectal Disease

Volumn 5, Issue 5, 2003, Pages 490-495

  Sjödahl, Rune I ^a   Myrelid, P ^a   Soderholm J D ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anal cancer; Crohn's disease; Epidemiology; Pathology; Rectal cancer; Surveillance

Indexed keywords

ADULT; ANUS CANCER; ANUS DISEASE; ARTICLE; CANCER RISK; CANCER STAGING; COLON RESECTION; COLORECTAL CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALE; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; RECTUM RESECTION; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; ANUS NEOPLASMS; CROHN DISEASE; HUMANS; INCIDENCE; RECTAL NEOPLASMS; RISK FACTORS;

EID: 0042328183     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2003.00510.x     Document Type: Article

References (44)

1. Warren S, Sommers SC. Cicatrizing enteritis (regional enteritis) as a pathological entity. Am J Pathol 1948; 24: 475-501.
2. Shorter RG. Risks of intestinal cancer in Crohn's disease. Dis Colon Rectum 1983; 26: 686-9.
3. Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease - based on results from a regional patient group from the County of Copenhagen. Gut 1985; 26: 146-50.
4. Kvist N, Jacobsen O, Norgaard P et al. Malignancy in Crohn's disease. Scand J Gastroenterol 1986; 21: 82-6.
5. Gollop JH, Phillips SF, Melton LJ, Zinsmeister AR. Epidemiological aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-82. Gut 1988; 29: 49-56.
6. Fireman Z, Grossman A, Lilos P et al. Intestinal cancer in patients with Crohn's disease: a population study in central Israel. Scand J Gastroenterol 1988; 24: 346-50.
7. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993; 105: 1716-23.
8. Persson PG, Karlén P, Bernell O et al. Crohn's disease and cancer: a population-based cohort study. Gastroenterology 1994; 107: 1675-9.
9. Mellemkjaer L, Johansen C, Gridley G, Linet MS, Kjaer SK, Olsen JH. Crohn's disease and cancer risk (Denmark). Cancer Causes Control 2000; 11: 145-50.
10. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-9.
11. Bernstein CN, Blanchard JF, Kliever E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001; 91: 854-62.
12. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn's disease and colorectal cancer. Gut 1994; 35: 651-5.
13. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1507-8.
14. Kyle J, Ewen SW. Two types of colorectal carcinoma in Crohn's disease. Ann R Coll Surg Engl 1992; 74: 387-90.
15. Andersson P, Olaison G, Myrelid P, Sjödahl R. (unpublished observation) 2003.
16. Askling J, Dickman PW, Karlén P et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 2001; 357: 246-7.
17. Fonager K, Sørensen HT, Mellemkjaer L, Olsen JH, Olsen J. Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark). Cancer Causes Control 1998; 9: 389-92.
18. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer 2000; 83: 89-90.
19. Slater G, Greenstein A, Aufses AH Jr. Anal carcinoma in patients with Crohn's disease. Ann Surg 1984; 199: 348-50.
20. Frisch M, Glimelius B, van den Brule AJ et al. Benign anal lesions, inflammatory bowel disease and risk for high-risk human papillomavirus-positive and - negative anal carcinoma. Br J Cancer 1998; 78: 1534-8.
21. Gilbert JM, Mann CV, Scholefield J, Domizio P. The aetiology of carcinoma of the anus, rectum and sigmoid colon in Crohn's disease. Negative correlation with human papillomavirus type 16 (HPV 16). Eur J Surg Oncol 1991; 17: 507-13.
22. Stahl TJ, Schoetz DJ, Roberts PL et al. Crohn's disease and carcinoma: Increasing justification for surveillance? Dis Colon Rectum 1992; 35: 850-6.
23. Richards ME, Rickert RR, Nance FC. Crohn's disease-associated carcinoma. A poorly recognized complication of inflammatory bowel disease. Ann Surg 1989; 209: 764-73.
24. Korelitz BI, Lauwers GY, Sommers SC. Rectal mucosal dysplasia in Crohn's disease. Gut 1990; 12: 1382-6.
25. Igarashi T, Akimoto S, Otasiro Y, Hanyu F, Nagasako K. Precancerous lesions of the colon and rectum. Gan Kagaku Ryoho 1989; 16: 1639-44.
26. Petras RE, Mir-Madjlessi SH, Farmer RG. Crohn's disease and intestinal carcinoma: a report of 11 cases with emphasis on associated epithelial dysplasia. Gastroenterology 1987; 93: 1307-14.
27. Hamilton SR. Colorectal carcinoma in patients with Crohn's disease. Gastroenterology 1985; 89: 398-407.
28. Warren R, Barwick KW. Crohn's colitis with carcinoma and dysplasia: report of 100 small and large bowel resections for Crohn's disease to detect the incidence of dysplasia. Am J Surg Pathol 1983; 7: 151-9.
29. Connell WR, Sheffield JP, Kamm MA, Hawley PR, Lennard-Jones JE. Lower gastrointestinal malignancy in Crohn's disease. Gut 1994; 35: 347-52.
30. Nikias G, Eisner T, Katz S et al. Crohn's disease and colorectal carcinoma: rectal cancer complicating longstanding active perianal disease. Am J Gastroenterol 1995; 90: 216-9.
31. Walgenbach S, Junginger T, Rothmund M, Nagel K. Crohn disease and squamous cell carcinoma of the anorectal transition. Chirurg 1987; 58: 248-51.
32. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998; 41: 992-6.
33. Winslett MC, Allan A, Ambrose NS. Anorectal sepsis as a presentation of occult rectal and systemic disease. Dis Colon Rectum 1988; 31: 597-600.
34. Nelson RL, Prasad L, Abcarian H. Anal carcinoma presenting as a perirectal abscess or fistula. Arch Surg 1985; 120: 632-5.
35. Freeman HJ. Colorectal cancer complicating Crohn's disease. Can J Gastroenterol 2001; 14: 231-6.
36. Cirincione E, Gorfine SR, Bauer JJ. Is Hartmann's procedure safe in Crohn's disease? Report of three cases. Dis Colon Rectum 2000; 43: 544-7.
37. Geoghegan JG, Carton E, O'Shea AM et al. Crohn's colitis. the fate of the rectum. Int J Colorectal Dis 1998; 13: 256-9.
38. Lavery IC, Jagelman DG. Cancer in the excluded rectum following surgery for inflammatory bowel disease. Dis Colon Rectum 1982; 25: 522-4.
39. Green S, Stock RG, Greenstein AJ. Rectal cancer and inflammatory bowel disease: natural history and implication for radiation therapy. Int J Radiol Oncol Biol Phys 1999; 44: 835-40.
40. Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 1996; 91: 44-8.
41. Lapidus A. The changing epidemiology of inflammatory bowel diseases. Acta Gastroenterol 2002; 64: 155-9.
42. Kinlen LJ, Sheil AGR, Peto J, Doll RA. Collaborative UK-Australian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461-6.
43. Choi PM, Zelig Mp. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35: 950-4.
44. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med 2000; 67: 227-9.